Price to Book Value Chart

View Price to Book Value for IVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2020. Start Trial.
Date Value
September 17, 2026 2.115
September 16, 2026 2.138
September 15, 2026 2.177
September 14, 2026 2.189
September 11, 2026 2.268
September 10, 2026 2.335
September 09, 2026 2.510
September 08, 2026 2.634
September 04, 2026 2.696
September 03, 2026 2.730
September 02, 2026 2.742
September 01, 2026 2.691
August 31, 2026 2.640
August 28, 2026 2.654
August 27, 2026 2.764
August 26, 2026 2.719
August 25, 2026 2.646
August 24, 2026 2.651
August 21, 2026 2.640
August 20, 2026 2.623
August 19, 2026 2.685
August 18, 2026 2.617
August 17, 2026 2.651
August 14, 2026 2.595
August 13, 2026 2.595
Date Value
August 12, 2026 2.640
August 11, 2026 2.662
August 10, 2026 2.679
August 07, 2026 2.708
August 06, 2026 2.629
August 05, 2026 2.662
August 04, 2026 2.544
August 03, 2026 2.397
July 31, 2026 2.527
July 30, 2026 2.606
July 29, 2026 2.544
July 28, 2026 2.617
July 27, 2026 2.595
July 24, 2026 2.516
July 23, 2026 2.544
July 22, 2026 2.561
July 21, 2026 2.527
July 20, 2026 2.490
July 17, 2026 2.606
July 16, 2026 2.550
July 15, 2026 2.522
July 14, 2026 2.482
July 13, 2026 2.426
July 10, 2026 2.426
July 09, 2026 2.555

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Nicox SA --
DBV Technologies SA 3.518
Cellectis SA 3.727
Genfit SA --
Innate Pharma SA --

Price to Book Value Related Metrics

PS Ratio 116.09
PEG Ratio -0.1674
Price 3.765
Earnings Yield -75.45%
Market Cap 727.54M
PEGY Ratio -0.1674